Medlogix

Capital Solutions & ALBA Hyperthermia: Advanced Oncology Hyperthermia in Egypt

Capital Solutions serves as the trusted representative and partner for ALBA Hyperthermia systems in Egypt, bringing state-of-the-art superficial, deep, and regional oncological hyperthermia solutions to leading public and private hospitals, radiotherapy centers, and oncology clinics.

As part of our commitment to introducing cutting-edge radiotherapy and oncology technologies to the Egyptian healthcare sector, Capital Solutions partners with ALBA Hyperthermia to supply, integrate, and support advanced thermal therapy systems—such as the ALBA 4000D.

Through this collaboration, Egyptian oncology departments gain access to clinically proven, ESHO-compliant hyperthermia equipment that acts as a powerful radiosensitizer and chemosensitizer. Capital Solutions provides end-to-end support, covering clinical site preparation, technical deployment, professional training, and continuous maintenance to ensure safe and effective patient treatments.

Key Partnership Highlights & Scope:

• Exclusive Representation & Supply: Bringing world-class ALBA hyperthermia technology directly to Egypt's oncology infrastructure.

• Comprehensive Integration: Supporting installation, calibration, and 3D treatment planning integration (such as Plan2Heat) for superficial and semi-deep treatments.

• Clinical Enhancement: Empowering hospitals to boost radiotherapy and chemotherapy effectiveness, targeting radioresistant hypoxic cells without increasing systemic toxicity.

• Dedicated Technical Support: Backed by Capital Solutions' expert biomedical engineers to ensure zero downtime and optimal clinical performance.